Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 14/20 | 0.40 |
| ▸ | CYP11B1 | P15538 | 13/20 | 0.40 |
| ▸ | BCAT1 | P54687 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.36 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.36 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.36 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.36 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21928401 | 0.76 | CYP11B1 (0.48) | CYP11B2CYP11B1BCAT1GABRG2GABRB3 | |
| SCHEMBL792287 | 0.74 | TYK2 (0.38) | CYP11B2CYP11B1BCAT1HTTGABRA1 | |
| SCHEMBL15124655 | 0.73 | IDO1 (0.48) | BCAT1 | |
| SCHEMBL1586204 | 0.73 | CLK4 (0.41) | CYP11B2BCAT1HTTGABRA1GABRG2 | |
| SCHEMBL29912400 | 0.73 | CLK4 (0.41) | CYP11B2BCAT1HTTGABRA1GABRG2 | |
| SCHEMBL30725740 | 0.72 | CYP11B1 (0.42) | CYP11B2CYP11B1GABRA1GABRG2GABRB3 | |
| SCHEMBL1605889 | 0.72 | PDK2 (0.46) | CYP11B2CYP11B1BCAT1GABRA1GABRG2 | |
| SCHEMBL17436331 | 0.71 | CYP11B2 (0.41) | CYP11B2CYP11B1BCAT1GABRA1GABRG2 | |
| SCHEMBL2650897 | 0.70 | GABRA1 (0.36) | CYP11B2CYP11B1BCAT1GABRA1GABRG2 | |
| SCHEMBL2651420 | 0.70 | CUL4A (0.39) | CYP11B2CYP11B1BCAT1GABRA1GABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200381631-A1 | COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS | WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2020-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200381631-A1 | COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS | DRD5, DRD1, DRD2 | CYP11B2 1432/4885CYP11B1 1287/4885BCAT1 4012/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.